6 months ago
NVO
AnalystsEvan David SeigermanEvan David Seigerman's Stock Forecasts
AnalystsEvan David Seigerman
Sectors:
Industries:
Analyst Ranking
Top 23%
#1133 out of 5057 analysts
Average Return
+9.12%
Win Rate
46%21 out of 46
Risk vs Reward
Poor
Good
Evan David Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Candel Therapeutics IncCADL | +568.75% | $1.60 | $10.70 | 2023-05-15 - 2024-05-14 | Buy |
Morphic Holding IncMORF | +147.53% | $22.49 | $55.67 | 2023-09-28 - 2024-07-09 | Buy |
Eli Lilly & CoLLY | +81.93% | $306.82 | $558.19 | 2022-09-06 - 2023-09-05 | Buy |
Merus NvMRUS | +72.02% | $55.14 | $94.85 | 2025-05-23 - 2025-10-13 | Buy |
Neurogene IncNGNE | +70.46% | $18.55 | $31.62 | 2025-05-20 - 2025-10-13 | Buy |
Evan David Seigerman Analyst Color
Get additional color on Evan David Seigerman's coverage of popular stocks
8 months ago
MRK
10 months ago
NVO
2 years ago
PFE
Evan David Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abbvie IncABBV | 8 | Buy | $240.00 | +4.21% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 8 | Buy | $640.00 | +14.75% | Maintains | 2 months ago |
Replimune Group IncREPL | 4 | Sell | $2.00 | -56.14% | Downgrades | 3 months ago |
Neurogene IncNGNE | 2 | Buy | $26.00 | -17.77% | Maintains | 4 months ago |
Merus NvMRUS | 1 | Buy | $110.00 | +15.97% | Maintains | 5 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $28.00 | +39.58% | Maintains | 5 months ago |
Arvinas IncARVN | 1 | Buy | $10.00 | +2.04% | Maintains | 5 months ago |
Novo Nordisk A SNVO | 6 | Hold | $64.00 | +11.30% | Downgrades | 6 months ago |
Merck & Co IncMRK | 4 | Hold | $96.00 | +12.02% | Maintains | 8 months ago |
Amgen IncAMGN | 4 | Buy | $346.00 | +18.33% | Maintains | 9 months ago |
Morphic Holding IncMORF | 3 | Hold | $57.00 | N/A | Downgrades | a year ago |
Structure Therapeutics IncGPCR | 2 | Buy | $100.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 4 | Buy | $36.00 | N/A | Reiterates | a year ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $72.00 | N/A | Maintains | 2 years ago |
Candel Therapeutics IncCADL | 1 | Buy | $3.00 | N/A | Maintains | 2 years ago |
Eli Lilly & CoLLY | 1 | Buy | $396.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.